Posed to internal attributional style [77], making it difficult to adequately cope with setbacks [78]. Experiencing difficulties during treatment, as well as not improving, could be presumed to be negative for the patient, resulting in lower self-esteem and competency. Correlations between the factors give some support for this idea, as both symptoms and hopelessness revealed moderate to large associations with failure. The ETQ mentions failure in one of its items [39], but only in terms of the therapist making the patient feel incompetent. Feelings of failure could be particularly damaging if it leads to drop out and prevents the patient from seeking treatment in the future, suggesting that the NEQ might be useful for monitoring this issue more closely. As to the items that were most frequently endorsed as occurring during treatment, unpleasant memories, stress, and anxiety were each experienced by more than one-third of the participants in the current study. Other items associated with symptoms were also common, indicating that adverse and unwanted events linked to novel and Peficitinib clinical trials increased symptomatology in treatment should be reasonable to expect. This is further evidence by the fact that this factor alone accounted for 36.58 of the variance in the EFA. In addition, five items related to the quality of the treatment were each endorsed by at least one-quarter of the participants, suggesting that this too might constitute a recurrent type of negative effect. Items related to the same two factors also contributed with the highest self-rated negative impact, implying that perceiving the treatment or therapeutic relationship as deficient, or experiencing different types of symptoms could be harmful for the patient. Thus, in order to prevent negative effects from occurring, different actions might be necessary to ensure a good treatment-patient fit, i.e., the right type of treatment for a particular patient, instilling confidence, as well as dealing with the patient’s expectations of treatment and bond with the therapist. Additionally, monitoring and managing symptoms by using the NEQ would also be important [23], especially given the factPLOS ONE | DOI:10.1371/journal.pone.0157503 June 22,15 /The Negative Effects Questionnairethat many therapists are unaware or have not received adequate training of negative effects in treatment [79]. The current study indicates that negative effects of psychological treatments seem to occur and can be assessed using the NEQ, Roc-A biological activity revealing several distinct but interrelated factors. Several limitations, however, need to be considered in reviewing the results. First, distribution of the instrument was made to patients at post treatment assessment or to individuals remembering their treatment retrospectively, with few participants presently being in treatment. Thus, there is a strong risk of recall effects exerting an influence, e.g., forgetting some adverse and unwanted events that have occurred, or only recognizing negative effects that happened early on or very late in treatment, i.e., primacy-recency effects [48]. Administering the NEQ on more than one occasion, e.g., mid-assessment, could perhaps prevent some of this problem and is therefore recommended in future studies. Although, recurrently probing for negative effects may pose a risk of inadvertently inducing adverse and unwanted events, i.e., making the patient more aware of certain incidents, which also needs to be recognized. Moreover, it may be importan.Posed to internal attributional style [77], making it difficult to adequately cope with setbacks [78]. Experiencing difficulties during treatment, as well as not improving, could be presumed to be negative for the patient, resulting in lower self-esteem and competency. Correlations between the factors give some support for this idea, as both symptoms and hopelessness revealed moderate to large associations with failure. The ETQ mentions failure in one of its items [39], but only in terms of the therapist making the patient feel incompetent. Feelings of failure could be particularly damaging if it leads to drop out and prevents the patient from seeking treatment in the future, suggesting that the NEQ might be useful for monitoring this issue more closely. As to the items that were most frequently endorsed as occurring during treatment, unpleasant memories, stress, and anxiety were each experienced by more than one-third of the participants in the current study. Other items associated with symptoms were also common, indicating that adverse and unwanted events linked to novel and increased symptomatology in treatment should be reasonable to expect. This is further evidence by the fact that this factor alone accounted for 36.58 of the variance in the EFA. In addition, five items related to the quality of the treatment were each endorsed by at least one-quarter of the participants, suggesting that this too might constitute a recurrent type of negative effect. Items related to the same two factors also contributed with the highest self-rated negative impact, implying that perceiving the treatment or therapeutic relationship as deficient, or experiencing different types of symptoms could be harmful for the patient. Thus, in order to prevent negative effects from occurring, different actions might be necessary to ensure a good treatment-patient fit, i.e., the right type of treatment for a particular patient, instilling confidence, as well as dealing with the patient’s expectations of treatment and bond with the therapist. Additionally, monitoring and managing symptoms by using the NEQ would also be important [23], especially given the factPLOS ONE | DOI:10.1371/journal.pone.0157503 June 22,15 /The Negative Effects Questionnairethat many therapists are unaware or have not received adequate training of negative effects in treatment [79]. The current study indicates that negative effects of psychological treatments seem to occur and can be assessed using the NEQ, revealing several distinct but interrelated factors. Several limitations, however, need to be considered in reviewing the results. First, distribution of the instrument was made to patients at post treatment assessment or to individuals remembering their treatment retrospectively, with few participants presently being in treatment. Thus, there is a strong risk of recall effects exerting an influence, e.g., forgetting some adverse and unwanted events that have occurred, or only recognizing negative effects that happened early on or very late in treatment, i.e., primacy-recency effects [48]. Administering the NEQ on more than one occasion, e.g., mid-assessment, could perhaps prevent some of this problem and is therefore recommended in future studies. Although, recurrently probing for negative effects may pose a risk of inadvertently inducing adverse and unwanted events, i.e., making the patient more aware of certain incidents, which also needs to be recognized. Moreover, it may be importan.
